Discovery of ligands for the nuclear peroxisome proliferator-activated receptors

Timothy M. Willson, Jürgen M. Lehmann, Steven A. Kliewer

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The identification of high-affinity ligands for PPARγ has revealed the role of this receptor as the molecular target for the antidiabetic activity of the thiazolidinediones. The surprising observation that agonists of an adipogenic transcription factor reverse the obesity-associated disease of diabetes highlights the power of using potent and selective ligands to study receptor-mediated biology. Similarly, the observation that PGD2 and its cyclopentenone metabolites compounds are μM PPAR ligands suggests that these receptors may have a physiological role in mediating prostaglandin signaling in the spleen.

Original languageEnglish (US)
Pages (from-to)276-283
Number of pages8
JournalAnnals of the New York Academy of Sciences
Volume804
DOIs
StatePublished - 1996

Fingerprint

Peroxisome Proliferator-Activated Receptors
Ligands
Prostaglandin D2
Thiazolidinediones
Medical problems
Metabolites
Hypoglycemic Agents
Prostaglandins
Transcription Factors
Spleen
Obesity
Transcription
Diabetes
Affinity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Discovery of ligands for the nuclear peroxisome proliferator-activated receptors. / Willson, Timothy M.; Lehmann, Jürgen M.; Kliewer, Steven A.

In: Annals of the New York Academy of Sciences, Vol. 804, 1996, p. 276-283.

Research output: Contribution to journalArticle

@article{f3f3f927cd414cc488b4d9e50e1bcaf6,
title = "Discovery of ligands for the nuclear peroxisome proliferator-activated receptors",
abstract = "The identification of high-affinity ligands for PPARγ has revealed the role of this receptor as the molecular target for the antidiabetic activity of the thiazolidinediones. The surprising observation that agonists of an adipogenic transcription factor reverse the obesity-associated disease of diabetes highlights the power of using potent and selective ligands to study receptor-mediated biology. Similarly, the observation that PGD2 and its cyclopentenone metabolites compounds are μM PPAR ligands suggests that these receptors may have a physiological role in mediating prostaglandin signaling in the spleen.",
author = "Willson, {Timothy M.} and Lehmann, {J{\"u}rgen M.} and Kliewer, {Steven A.}",
year = "1996",
doi = "10.1111/j.1749-6632.1996.tb18622.x",
language = "English (US)",
volume = "804",
pages = "276--283",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Discovery of ligands for the nuclear peroxisome proliferator-activated receptors

AU - Willson, Timothy M.

AU - Lehmann, Jürgen M.

AU - Kliewer, Steven A.

PY - 1996

Y1 - 1996

N2 - The identification of high-affinity ligands for PPARγ has revealed the role of this receptor as the molecular target for the antidiabetic activity of the thiazolidinediones. The surprising observation that agonists of an adipogenic transcription factor reverse the obesity-associated disease of diabetes highlights the power of using potent and selective ligands to study receptor-mediated biology. Similarly, the observation that PGD2 and its cyclopentenone metabolites compounds are μM PPAR ligands suggests that these receptors may have a physiological role in mediating prostaglandin signaling in the spleen.

AB - The identification of high-affinity ligands for PPARγ has revealed the role of this receptor as the molecular target for the antidiabetic activity of the thiazolidinediones. The surprising observation that agonists of an adipogenic transcription factor reverse the obesity-associated disease of diabetes highlights the power of using potent and selective ligands to study receptor-mediated biology. Similarly, the observation that PGD2 and its cyclopentenone metabolites compounds are μM PPAR ligands suggests that these receptors may have a physiological role in mediating prostaglandin signaling in the spleen.

UR - http://www.scopus.com/inward/record.url?scp=0030451897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030451897&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1996.tb18622.x

DO - 10.1111/j.1749-6632.1996.tb18622.x

M3 - Article

VL - 804

SP - 276

EP - 283

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -